THE INTRADAY

WST · Company KPIs

West Pharmaceutical Services (WST) KPIs

HVP Components share of total net sales, Biologics share of net sales (market group), HVP Delivery Devices share of total net sales. As reported in SEC filings, with the source line for each figure.

HVP Components share of total net sales

53% for the period ended Sep 30, 2026

Jun 30, 2025: ≈ 47%Sep 30, 2025: 48%Dec 31, 2025: 48%Mar 31, 2026: 48%Jun 30, 2026: 49%Sep 30, 2026: 53%Jun 30, 2025Sep 30, 2026

The filings read for this page do not define this measure.

HVP Components share of total net sales, as first reported, with the line it was read from
Period endedFigureFiling text
Sep 30, 202653%HVP Components accounted for 53% of total company net sales in the quarter.8-K filed 2026-10-29
Jun 30, 202649%HVP Components accounted for 49% of total company net sales in the quarter.8-K filed 2026-07-23
Mar 31, 202648%HVP Components accounted for 48% of total company net sales in the quarter.8-K filed 2026-04-23
Dec 31, 202548%HVP Components accounted for 48% of total company net sales in the quarter.8-K filed 2026-02-12
Sep 30, 202548%HVP Components accounted for 48% of total company net sales in the quarter.8-K filed 2025-10-23
Jun 30, 2025≈ 47%As the company words itHigh-Value Product ("HVP") Components · 49 % · 47 % · 48 % · 46 %10-Q filed 2026-07-23

Biologics share of net sales (market group)

43% for the period ended Sep 30, 2026

Jun 30, 2025: ≈ 38%Sep 30, 2025: 41%Dec 31, 2025: 42%Mar 31, 2026: 42%Jun 30, 2026: 43%Sep 30, 2026: 43%Jun 30, 2025Sep 30, 2026

The filings read for this page do not define this measure.

Biologics share of net sales (market group), as first reported, with the line it was read from
Period endedFigureFiling text
Sep 30, 202643%Biologics $379.3 15.3% (0.4%) 7.5% 23.2% 43%8-K filed 2026-10-29
Jun 30, 202643%Biologics $374.8 30.3% 1.1% 29.2% 43%8-K filed 2026-07-23
Mar 31, 202642%Biologics $354.5 31.6% 5.7% 25.9% 42%8-K filed 2026-04-23
Dec 31, 202542%Biologics* $340.4 11.5% 4.2% 7.3% 42%8-K filed 2026-02-12
Sep 30, 202541%41% of West’s revenue in 3Q258-K filed 2025-10-23
Jun 30, 2025≈ 38%As the company words itBiologics · 43 % · 38 % · 42 % · 38 %10-Q filed 2026-07-23

HVP Delivery Devices share of total net sales

11% for the period ended Sep 30, 2026

Jun 30, 2025: ≈ 13%Sep 30, 2025: 12%Dec 31, 2025: 14%Mar 31, 2026: 15%Jun 30, 2026: 15%Sep 30, 2026: 11%Jun 30, 2025Sep 30, 2026

The filings read for this page do not define this measure.

HVP Delivery Devices share of total net sales, as first reported, with the line it was read from
Period endedFigureFiling text
Sep 30, 202611%HVP Delivery Devices accounted for 11% of total company net sales in the quarter.8-K filed 2026-10-29
Jun 30, 202615%HVP Delivery Devices accounted for 15% of total company net sales in the quarter.8-K filed 2026-07-23
Mar 31, 202615%HVP Delivery Devices accounted for 15% of total company net sales in the quarter.8-K filed 2026-04-23
Dec 31, 202514%HVP Delivery Devices accounted for 14% of total company net sales in the quarter.8-K filed 2026-02-12
Sep 30, 202512%HVP Delivery Devices accounted for 12% of total company net sales in the quarter.8-K filed 2025-10-23
Jun 30, 2025≈ 13%As the company words itHigh-Value Product ("HVP") Delivery Devices · 15 % · 13 % · 15 % · 13 %10-Q filed 2026-07-23

Reading notes

Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.